Kara Penne
- Genetics top 2%
- Glioma Diagnosis and Treatment 2
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 4
- Colorectal Cancer Treatments and Studies 2
-
- Esophageal and GI Pathology 3
-
- Clinical practice guidelines implementation 2
-
- Central Venous Catheters and Hemodialysis 2
-
- Urinary Tract Infections Management 1
-
- RNA modifications and cancer 1
- Co-authors
- James E. HerndonJennifer A. QuinnJames J. VredenburghHenry S. FriedmanJeremy N. RichDavid A. ReardonDarell D. BignerAllan H. Friedman
- Cited by
- GeneticsCancer ResearchOncology
- Journals
- Journal of Clinical Oncology (2 papers)Neuro-Oncology (1 paper)Journal of Surgical Research (2 papers)
- Partner nations
- United StatesFrance
In The Last Decade
Kara Penne
11 papers receiving 671 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Genetics 375
- Cancer Research 154
- Oncology 256
- Pulmonary and Respiratory Medicine 203
- Pathology and Forensic Medicine 88
Countries citing papers authored by Kara Penne
This map shows the geographic impact of Kara Penne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara Penne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara Penne more than expected).
Fields of papers citing papers by Kara Penne
This network shows the impact of papers produced by Kara Penne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara Penne. The network helps show where Kara Penne may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kara Penne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 3 | |
| 2 | 2014 | 12 | |
| 3 | 2014 | 43 | |
| 4 | 2014 | 21 | |
| 5 | 2006 | 11 | |
| 6 | 2005 | 30 | |
| 7 | Results of a phase II trial with iodine 131-labeled murine antitenascin monoclonal antibody 81C6 (m81C6) via surgically created resection cavities in the treatment of patients with recurrent malignant brain tumors | 2004 | 1 |
| 8 | 2004 | 2 | |
| 9 | Phase II Trial of Gefitinib in Recurrent Glioblastomabreakdown → | 2003 | 558 |
| 10 | 2003 | 1 | |
| 11 | 2002 | 9 |
About Kara Penne
Kara Penne is a scholar working on Emergency Medical Services, Oncology and Critical Care and Intensive Care Medicine, having authored 11 papers that have together received 691 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Esophageal and GI Pathology (3 papers), Clinical practice guidelines implementation (2 papers), Central Venous Catheters and Hemodialysis (2 papers), Glioma Diagnosis and Treatment (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Urinary Tract Infections Management (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Genetics (375 citations), Cancer Research (154 citations) and Oncology (256 citations). Kara Penne has collaborated with scholars based in United States and France. Frequent co-authors include James E. Herndon, Jennifer A. Quinn, James J. Vredenburgh, Henry S. Friedman, Jeremy N. Rich, David A. Reardon, Darell D. Bigner, Allan H. Friedman, Jeannette M. Dowell and Carol J. Wikstrand. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.